Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
about
Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema ComplicationsMonitoring cerebral oxygenation during balloon occlusion with multichannel NIRS.Development of a computerised decision aid for thrombolysis in acute stroke care.Frequency and risk factors of spontaneous hemorrhagic transformation following ischemic stroke on the initial brain CT or MRI: data from the China National Stroke Registry (CNSR).Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials.Pathophysiology of acute middle cerebral artery infarct by multimodal computed tomography: A pilot study in Thai patients.Development of a decision analytic model to support decision making and risk communication about thrombolytic treatmentThe role of additional computed tomography in the decision-making process on the secondary prevention in patients after systemic cerebral thrombolysis.Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational studyIntravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies.Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies.Combining antithrombotic and fibrinolytic agents: can it be done?Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous ThrombolysisThe human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signalingAcute stroke management in patients taking dabigatran.Clinical predictors and management of hemorrhagic transformation.Paroxysmal atrial fibrillation after ischemic stroke: how should we hunt for it?Multisociety consensus quality improvement guidelines for intraarterial catheter-directed treatment of acute ischemic stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and InterventionOutcomes after stroke thrombolysis according to prior antiplatelet use.Intravenous thrombolysis for acute stroke: current standards and future directions.TPA for ischemic stroke in patients ≥80 years.Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke.Simultaneous acute cardio-cerebral infarction: is there a consensus for management?[Difficult decisions in stroke therapy].
P2860
Q26796470-0E70088B-AE3A-4654-A7BE-3F35C3922AE4Q30443283-D34EC595-188E-4A76-93D3-D9AB69C8E2D6Q30620347-0A828B65-8B46-4159-9974-AD88F9414281Q31109008-21996BF9-4CA1-4FA3-A7D9-80A6ACF86EA8Q34006140-DDF45103-D3DD-47F4-AA9B-307EEF16CA57Q34418517-19C74EAF-A64D-49E3-87BF-1F1F50C9F322Q34574766-1733E573-746F-434D-9DFE-D38E7AFB06D3Q35839054-C3115955-AE64-475E-8D18-6A4DF7FB0BE2Q36412737-712A213B-B8D3-403A-9F7C-0A11B01FC4DAQ36620631-FBADFC1B-52DC-46AC-A0E5-5A6B01AA6A3CQ36956762-A680CAB8-0E29-4B5E-A91C-D649AC14EA83Q37052824-906A85A3-336D-4629-B979-176252A1D533Q37342895-7262AFFA-CF26-40B3-A5E5-A8D9680EEE90Q37343410-30B565DC-58B2-4D1D-BB3D-91F7890203EEQ37467900-D07AC9ED-03FC-40E2-8E42-941BC56C924AQ38005465-3911ACD5-92AE-4671-82D6-3C4DA05AC9C1Q38074569-3D99753D-BBB5-498C-9775-DF670A9E8BB7Q38097511-A8DF180A-586F-444F-8B4C-6C3E1D78F91EQ38103827-A965B681-BA14-497F-A81F-65C8F8E62086Q38285447-ECB03888-7D26-4A16-888A-7F83AFCB0B35Q39028528-E6968DB9-EBCF-4798-8CC8-7986BFAE243EQ41973729-6A68DCAD-92E0-4D29-BBB6-41E4A74BE4D9Q48591320-DD413A06-47B2-4BD1-8BF7-7970CA621B6AQ50060901-778BFB04-09A1-48B4-A2D4-55AA18EB5ADAQ52893837-C5515684-BD44-407D-8206-6DDD20C40FE3
P2860
Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Factors associated with intrac ...... (SAINT) I and SAINT II Trials.
@ast
Factors associated with intrac ...... (SAINT) I and SAINT II Trials.
@en
type
label
Factors associated with intrac ...... (SAINT) I and SAINT II Trials.
@ast
Factors associated with intrac ...... (SAINT) I and SAINT II Trials.
@en
prefLabel
Factors associated with intrac ...... (SAINT) I and SAINT II Trials.
@ast
Factors associated with intrac ...... (SAINT) I and SAINT II Trials.
@en
P2093
P1433
P1476
Factors associated with intrac ...... (SAINT) I and SAINT II Trials.
@en
P2093
Andrew Demchuk
Brett Cucchiara
Kennedy R Lees
Lauren Sansing
Patrick Lyden
SAINT Investigators
Scott E Kasner
Steven R Levine
Steven R Messe
P304
P356
10.1161/STROKEAHA.109.554386
P407
P50
P577
2009-07-16T00:00:00Z